Mirae Asset Global Etfs Holdings Ltd. Bridge Bio Pharma, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 68,896 shares of BBIO stock, worth $1.87 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
68,896Holding current value
$1.87 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BBIO
# of Institutions
299Shares Held
178MCall Options Held
8.72MPut Options Held
2.75M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY31.1MShares$841 Million45.4% of portfolio
-
Viking Global Investors LP25.1MShares$681 Million2.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$381 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$337 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$164 Million67.33% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $4.02B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...